---

Comparative study of etomidate and fentanyl citrate with propofol (1%) and fentanyl citrate for total intravenous anaesthesia in short surgical procedures

Full Text PDF

---

Original Article

Author Details : Atikahmed Gulamdastagir Momin, Raushan Kumar Jha*, Madhuri A Bhade

Volume : 7, Issue : 2, Year : 2020

Article Page : 348-354

https://doi.org/10.18231/j.ijca.2020.063

Suggest article by email

Get Permission

Abstract

Total intravenous anaesthesia (TIVA) is a combination of Induction agents, analgesic drugs and
muscle relaxants, excluding simultaneous administration of any inhaled drugs. This study has major
objective, to determine the efficacy of Etomidate and Propofol (1%) as anaesthetic induction agents
in termed of Induction time, maintenance doses requirements and Recovery parameters. This study
suggests that both Etomidate–Fentanyl citrate and propofol (1%)–Fentanyl citrate produced smooth
induction, easy maintenance and quick recovery with only minor hemodynamic fluctuations makes them
excellent combinations as TIVA technique. Etomidate is preferred over Propofol (1%) especially for
hemodynamically unstable patients because of minimal effects on cardiovascular and respiratory system.
hypotension and pain on injection was observed more frequently with Propofol (1%) while myoclonus with
Etomidate. With these observations in mind and careful selection of patients, both agents appear similarly
safe for use in elective and short surgical procedures.

Keywords: Fentanyl, Propofol, TIVA, Etomidate.

How to cite : Momin A G, Jha R K, Bhade M A, Comparative study of etomidate and fentanyl citrate with propofol (1%) and fentanyl citrate for total intravenous anaesthesia in short surgical procedures. Indian J Clin Anaesth 2020;7(2):348-354

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.